Delivery Order SPE2DB22D3501-SPE2DB25FWM51
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $31,517.29 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 500 mg tablets (60-count units). This competitive, firm fixed-price contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,489.04 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count units) under a firm fixed-price contract. This non-competitive delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $9,372.25 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120 count) on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under a larger vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,340.06 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 500 mg tablets (60 count) on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical products will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count) valued at $13,701.92. This firm fixed-price delivery order is classified as non-competitive and will be completed by July 22, 2025. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $46,593.78 delivery order to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count) on August 19, 2025, with completion scheduled for August 20, 2025. This competitively awarded, firm fixed price contract has no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 17, 2025, for Abiroterone Acetate 500 mg tablets (60-count) with a ceiling value of $17,936.40. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and carries an ultimate completion date of June 18, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,023.83 on July 28, 2025, for the supply of Abiroterone Acetate 500 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 29, 2025, and fulfillment occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Abiroterone Acetate is a hormone therapy medication commonly used in cancer treatment, reflecting the Defense...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency Medical Supply Chain on September 8, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120 count) with a ceiling value of $16,030.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical delivery under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Abiroterone Acetate 500 mg tablets (60-count) with a ceiling value of $1,463.13. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This delivery order...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWM51Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,774.15 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120 count) on July 21, 2025, with completion scheduled for July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities. The arrangement demonstrates AmerisourceBergen Drug Corp's established role as a critical pharmaceutical vendor within the federal medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 7/21/25 |